Zacks Investment Research on MSN8hOpinion
5 Large Drug Stocks to Watch as Industry Recovers
The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...
Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...
Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior. “Three years ago, ...
In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...
The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain ...
Dawn Maroney became president of Alignment Health in January at a critical time for the health insurance industry.
Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers targeted for second round of Medicare price talks agreed to participate.
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...